On 14 July 2025, the Council of the State Duma began reviewing Draft Law No. 951518-8 “On Amendments to Article 12 of the Federal Law ‘On Personal Data’” (hereinafter referred to as the “Draft Law”).

On 7 July 2025, the President of the Russian Federation has signed the Federal Law No. 186-FZ of 07.07.2025 “On Amendments to Article 21 of the Federal Law “On Limited Liability Companies" (hereinafter the “Law”), which provides for amendments to the Federal Law No. 14-FZ of 08.02.1998 “On Limited Liability Companies” (hereinafter the “LLC Law”) taking effect on 1 September 2025 regarding the possibility of excluding the pre-emptive right to purchase a share or a part thereof.

On 7 July 2025, the President of the Russian Federation has signed the Federal Law No. 186-FZ of 07.07.2025 “On Amendments to Article 21 of the Federal Law “On Limited Liability Companies" (hereinafter the “Law”), which provides for amendments to the Federal Law No. 14-FZ of 08.02.1998 “On Limited Liability Companies” (hereinafter the “LLC Law”) taking effect on 1 September 2025 regarding the possibility of excluding the pre-emptive right to purchase a share or a part thereof.

On July 11, 2025, a joint letter from the FAS and the Ministry of Health № ТН/61566/25, № 25-7/И/2-13136 dated July 2, 2025 (hereinafter referred to as the "Joint Letter") was published, clarifying the procedure for determining the initial (maximum) contract price (IMCP) in the procurement of pharmaceuticals.

As part of the Lidings Global project and following its series of events focused on the Middle East, Lidings will run a seminar Future of Enforcement of Foreign Award: Russia, CIS, and the Middle East in collaboration with ALC Lawyers ALC Lawyers and Counsels, a leading Omani law firm.

The event will take place on July 22, 2025, at the Oman Commercial Arbitration Centre (OCAC) in Muscat.

Overview of changes in the sphere of information security and personal data (hereinafter referred to as the “PD”) that will affect the activities of organizations involved in the wholesale and retail trade of medicinal products. We remind you that starting from September 1, 2025, consents for PD processing must be stand-alone documents, separate from website Privacy Policies

On September 1, 2025, Federal Law No. 150-FZ dated June 7, 2025, 'On Amendments to Certain Legislative Acts of the Russian Federation' (hereinafter referred to as 'Federal Law No. 150'), will come into force, introducing a number of changes affecting the regulation of dietary supplements.

On June 24, 2025, the President of the Russian Federation signed Federal Law No. 178-FZ "On Amendments to Part One and Article 846 of Part Two of the Civil Code of the Russian Federation" ("Law"), which introduces amendments to the Civil Code of the Russian Federation ("Civil Code"), allowing one legal entity to be the sole participant or shareholder of another company, even if both are having the sole person in it.

On 23 July 2025, a part of the Good Clinical Practice Guideline, GCP E6 (R3), promulgated by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) comes into force. The development of new technologies, the rapidly evolving clinical trial (CT) ecosystem, and the need to respond quickly to deviations in CT processes have prompted the revision of the current version of GCP ICH E6(R2), which is valid until 22 July 2025.